The Feldman Protocol
In this episode of The Feldman Protocol, can living with an LDL of 700 for seven years actually leave your arteries plaque-free? Nick Norwitz (MD PhD) makes the case that the conventional cholesterol narrative is far more complicated than mainstream medicine admits, while Dave and Nick also cover the paternalistic medical system, statin side effects in women, Nick's surprising decision to take a cholesterol-lowering drug, and the recent Peter Attia rebuttal to lean mass hypersponder research. --- 🔥 This episode is sponsored by us -- Own Your Labs 👉 `https://ownyourlabs.com/sp/30` Private blood testing services 🩸Over 300 blood tests 💰Extremely affordable ❤️ We love our customers (Yes, we are literally funding the entire podcast from our own company -- so if you want to show your support, keep getting your private blood testing through our service. Thank you! 🙏) --- 🔗 CONNECT WITH DAVE FELDMAN: Main Channel: `https://youtube.com/@realDaveFeldman` X/Twitter: `https://x.com/realDaveFeldman` Instagram: `https://instagram.com/realDaveFeldman` Website: `https://thefeldmanprotocol.com` --- ⏱ Chapters 3:03 – Who is Nick Norwitz? 3:51 – Leaving medicine's conventional path 5:52 – The calling Dave never felt 8:23 – Science communication as medicine's future 10:30 – Empowering patients with information 11:24 – Statins lower GLP-1: the hidden data 13:10 – Death knell of paternalistic medicine 16:19 – Dave's origin: The Feldman Protocol 18:31 – Why "we don't know" comforts patients 21:43 – Nick's illness, misdiagnosis & obsession 24:04 – The podcast origin story & echo disaster 28:41 – Cholesterol Code film blowing up 31:19 – Balancing science and accessibility in film 36:06 – Peter Attia's rebuttal to LMHR research 38:18 – Who's willing to have an open conversation? 41:01 – Causality vs. importance in lipid science 44:17 – Over-medicating metabolically healthy people 47:01 – Statins harm women more: the X chromosome mechanism 50:45 – The nocebo effect as gaslighting 55:03 – Dave's blinded crossover statin experiment 57:04 – Plot twist: Nick is taking a cholesterol drug 59:05 – Ezetimibe and Alzheimer's disease 1:02:01 – Plot twist 2: why Nick chose ezetimibe 1:04:00 – Plot twist 3: the 7-year coronary CT angiography 1:08:19 – Nick's CAD score at year 2 & family risk 1:14:10 – Clinical experience vs. contending with data 1:23:33 – Is Nick anti-statin? Dave presses hard 1:27:34 – Bempedoic acid & PPAR alpha activation 1:32:39 – Peter Attia's article vs. the LMHR team 1:36:24 – How to find Nick Norwitz everywhere --- #FeldmanProtocol #DaveFeldman #NickNorwitz #LDLCholesterol #LeanMassHypersponder #CholesterolCode #StatinSideEffects #Ezetimibe #HeartHealth #LipidResearch #MetabolicHealth #Atherosclerosis #PatientEmpowerment #ScienceCommunication #Bempedoicacid #AlzheimersResearch #CardiovascularHealth #LowCarb #KetogenicDiet
32 episodios
Comentarios
0Sé la primera persona en comentar
¡Regístrate ahora y únete a la comunidad de The Feldman Protocol!